Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mee Sook Rho"'
Autor:
Sang Hwa Lee, Wan Seop Kim, Yoo Duk Choi, Jeong Wook Seo, Joung Ho Han, Mi Jin Kim, Lucia Kim, Geon Kook Lee, Chang Hun Lee, Mee Hye Oh, Gou Young Kim, Sun Hee Sung, Kyo Young Lee, Sun Hee Chang, Mee Sook Rho, Han Kyeom Kim, Soon Hee Jung, Se Jin Jang
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 49, Iss 6, Pp 481-488 (2015)
Background: Analysis of mutations in the epidermal growth factor receptor gene (EGFR) is important for predicting response to EGFR tyrosine kinase inhibitors. The overall rate of EGFR mutations in Korean patients is variable. To obtain comprehensive
Externí odkaz:
https://doaj.org/article/6d2196ee6755481c916ba8896fcbe836
Autor:
Mi Jin Kim, Se Jin Jang, Mee Sook Rho, Jeong-Wook Seo, Sang Hwa Lee, Soon Hee Jung, Wan Seop Kim, Mee Hye Oh, Geon Kook Lee, Lucia Kim, Kyo Young Lee, Sun Hee Sung, Gou Young Kim, Joungho Han, Chang Hun Lee, Yoo Duk Choi, Sun Hee Chang, Han Kyeom Kim
Publikováno v:
Journal of Pathology and Translational Medicine
Journal of Pathology and Translational Medicine, Vol 49, Iss 6, Pp 481-488 (2015)
Journal of Pathology and Translational Medicine, Vol 49, Iss 6, Pp 481-488 (2015)
Lung cancer is the leading cause of cancer-related death in Korea, accounting for approximately 20% of all cancer deaths [1]. Non-small cell lung cancer (NSCLC) accounts for more than 85% of all lung cancers, and the majority of patients with NSCLC p
Publikováno v:
Korean Journal of Ophthalmology : KJO
Malignant lymphomas represent approximately 10% of orbital tumors.1-4 In addition, 5-8% of extranodal lymphomas involve the orbit, and 1.3-2.0% of extranodal lymphomas appear as primary orbital tumors.3,5 The incidence of primary orbital tumors has r
Autor:
Joo-In Park, Dae-Cheol Kim, Jin-Sook Jeong, Seung-Hee Hong, Bum-Sik Hong, Mee-Sook Rho, Ho-Sun Jun, Soe-Hee Rha
Publikováno v:
Experimental & Molecular Medicine. 36:493-498
Hydroxyurea is commonly used to treat hematologic disorders and some type of solid tumors, but the mechanism for its therapeutic effect is not clearly known. In this study, we examined the effect of hydroxyurea on rat hepatoma McA-RH7777 cells, speci
Autor:
Kyung Taek Kim, Sung Keun Sohn, Mee Sook Rho, Myung Jin Lee, Chul Hong Kim, Min Ho Jeong, Sang Kyu Sun, Hee Bae Ahn
Publikováno v:
Clinics in Orthopedic Surgery
Background The aim of the present study was to prepare hydroxyapatite (HA) and then characterize its effect on bone integration in a rabbit tibial defect model. The bone formation with different designs of HA was compared and the bony integration of
Autor:
Mee-Sook Rho, Byung Geun Kim, Suee Lee, Sung Yong Oh, Hyo-Jin Kim, Hyukchan Kwon, Jin-Sook Jeong, Sunghyun Kim, Myung Hwan Rho, Young Hoon Kim
Publikováno v:
American journal of clinical oncology. 32(4)
Gemcitabine-based chemotherapy is a commonly used first-line treatment for patients with pancreatic and biliary tract cancer. However, a standard second-line chemotherapy regimen has yet to be developed after gemcitabine treatment. We attempted to ev
Publikováno v:
Oncology reports. 21(1)
Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) plays an essential role in angiogenesis and development. A previous study showed that the expression of COUP-TFII enhanced invasiveness of human lung carcinoma cells. However, no
Autor:
Suee Lee, Myung Hwan Rho, Sung Yong Oh, Young Hoon Kim, Jaehyuk Choi, Jung Hwan Kim, Jae Hoon Lee, Dong Mee Lee, Mee-Sook Rho, Hyo-Jin Kim, Sung-Hyun Kim, Hyuk-Chan Kwon
Publikováno v:
Cancer Research and Treatment. 40:22
Gemcitabine is the most active agent to treat unresectable pancreatic cancer. The superiority of combining other drugs with cisplatin is still controversial; therefore, we performed a retrospective analysis of gemcitabine versus gemcitabine combined
Publikováno v:
Journal of the Korean Radiological Society. 48:153
Autor:
Hyuck Lee, Pil Jo Choi, Soo Keol Lee, Choon Hee Son, Mee Sook Rho, Ki Nam Lee, Doo Kyung Yang, Ik Soo Choi, Kwang Yul Chang, Jin Sook Jeong
Publikováno v:
Tuberculosis and Respiratory Diseases. 51:416
Background : The incidence of drug-resistant tuberculosis has recently decreased in Korea. However, it is still one of the major obstacles in treating pulmonary tuberculosis. This study was performed to determine the prevalence and clinical character